Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T E Witzig

Showing results (1-10 of 183) with videos related to

Pageof 19
Sort By:
Cancer Chemotherapy and Pharmacology|October 6, 2001
Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphomaT E Witzig
Mayo Clinic Proceedings|September 1, 1994
Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applicationsT E Witzig
Seminars in Oncology|February 28, 2001
The use of ibritumomab tiuxetan radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphomaT E Witzig
Hematology/Oncology Clinics of North America|January 8, 2000
The role of adhesion receptors in the pathogenesis of multiple myelomaT E Witzig
Bone Marrow Transplantation|March 2, 1997
Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myelomaT Kimlinger, T E Witzig
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2014
Incidence of bowel perforation in gastrointestinal lymphomas by location and histologyR Vaidya, T E Witzig
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP eraR Vaidya, T E Witzig
British Journal of Haematology|December 3, 1999
Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous signD P Steensma, T E Witzig
Cancer Treatment Reviews|September 28, 2000
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myelomaS V Rajkumar, T E Witzig
Journal of Cellular and Molecular Medicine|August 10, 2002
Thalidomide as an anti-cancer agentS Kumar, T E Witzig, S V Rajkumar
Pageof 19

Showing results (1-10 of 183) with videos related to

Sort By:
Pageof 19
Cancer Chemotherapy and Pharmacology|October 6, 2001
Radioimmunotherapy for patients with relapsed B-cell non-Hodgkin lymphomaT E Witzig
Mayo Clinic Proceedings|September 1, 1994
Detection of malignant cells in the peripheral blood of patients with multiple myeloma: clinical implications and research applicationsT E Witzig
Seminars in Oncology|February 28, 2001
The use of ibritumomab tiuxetan radioimmunotherapy for patients with relapsed B-cell non-Hodgkin's lymphomaT E Witzig
Hematology/Oncology Clinics of North America|January 8, 2000
The role of adhesion receptors in the pathogenesis of multiple myelomaT E Witzig
Bone Marrow Transplantation|March 2, 1997
Expression of the hematopoietic stem cell antigen CD34 on blood and bone marrow monoclonal plasma cells from patients with multiple myelomaT Kimlinger, T E Witzig
Annals of Oncology : Official Journal of the European Society for Medical Oncology|April 3, 2014
Incidence of bowel perforation in gastrointestinal lymphomas by location and histologyR Vaidya, T E Witzig
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 15, 2014
Prognostic factors for diffuse large B-cell lymphoma in the R(X)CHOP eraR Vaidya, T E Witzig
British Journal of Haematology|December 3, 1999
Elevated serum LDH in patients with non-Hodgkin's lymphoma: not always an ominous signD P Steensma, T E Witzig
Cancer Treatment Reviews|September 28, 2000
A review of angiogenesis and antiangiogenic therapy with thalidomide in multiple myelomaS V Rajkumar, T E Witzig
Journal of Cellular and Molecular Medicine|August 10, 2002
Thalidomide as an anti-cancer agentS Kumar, T E Witzig, S V Rajkumar
Pageof 19